Animal Models of Retinal Vein Occlusion
Open accessThe DOI matches its Crossref record; 208 of the 208 references it cites were found in a registry or an index.
Abstract
Purpose: To provide a comprehensive and current review on the available experimental animal models of retinal vein occlusion (RVO) and to identify their strengths and limitations with the purpose of helping researchers to plan preclinical studies on RVO. Methods: A systematic review of the literature on experimental animal models of RVO was undertaken. Medline, SCOPUS, and Web of Science databases were searched. Studies published between January 1, 1965, and March 31, 2017, and that met the inclusion criteria were reviewed. The data extracted included animal species used, methods of inducing RVO, and the clinical and histopathologic features of the models, especially in relation to strengths, limitations, and faithfulness to clinical sequelae. Results: A total of 128 articles fulfilling the inclusion criteria were included. Several species were used to model human branch and central RVO (BRVO; CRVO) with nonhuman primates being the most common, followed by rodents and pigs. BRVO and CRVO were most commonly induced by laser photocoagulation and all models showed early features of clinical disease, including retinal hemorrhages and retinal edema. These features made many of the models adequate for studying the acute phase of BRVO and CRVO, although macular edema, retinal ischemia, and neovascular complications were observed in only a few experimental animal models (laser-induced model in rodents, pigs, and nonhuman primates, diathermy-induced model in pigs, and following intravitreal injection of PD0325901 in rabbits for BRVO; and in the laser-induced model in rodents, rabbits, and nonhuman primates, diathermy-induced model in nonhuman primates, following permanent ligation of the central retinal vein in nonhuman primates, and with intravitreal injection of thrombin in rabbits for CRVO). Conclusions: Experimental animal models of RVO are available to study the pathogenesis of this disease and to evaluate diagnostic/prognostic biomarkers and to develop new therapeutics. Data available suggest laser-induced RVO in pigs and rodents to be overall the best models of BRVO and the laser-induced RVO rodents the best model for CRVO.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Ophthalmic AEs such as retinal vein occlusion and macular oedema are also amenable to preclinical modeling, where laser- or occlusion-based paradigms in rodents and larger species reproduce hallmark vascular and edema phenotypes that can be quantified by fundus imaging, and histopathology (Khayat et al., 2017).”
From A large-scale concordance study of toxicity findings across preclinical species and humans for small molecules and biologics (2026) · cites this paper as Khayat et al., 2017
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Part of this paper’s reference list could not be split into single entries.
Ranibizumab for Macular Edema following Central Retinal Vein Occlusion
Brown, D. M., Campochiaro, P. A., Singh, R. P., Li, Z., Gray, S., Saroj, N., Rundle, A. C., Rubio, R. G., & Murahashi, W. Y. (2010) · Ophthalmology · doi:10.1016/j.ophtha.2010.02.022 · Cited by 1,155
Haller, J. A., Bandello, F., Belfort, R., Blumenkranz, M. S., Gillies, M., Heier, J., Loewenstein, A., Yoon, Y.-H., Jacques, M.-L., Jiao, J., et al. (2010) · Ophthalmology · doi:10.1016/j.ophtha.2010.03.032 · Cited by 1,068
Miller, J. W., Adamis, A. P., Shima, D. T., D'Amore, P. A., Moulton, R. S., O'Reilly, M. S., Folkman, J., Dvorak, H. F., Brown, L. F., & Berse, B. (1994) · PubMed · Cited by 810
(2009) · Archives of Ophthalmology · doi:10.1001/archophthalmol.2009.234 · Cited by 674
Adamis, A. P. (1996) · Archives of Ophthalmology · doi:10.1001/archopht.1996.01100130062010 · Cited by 635
Natural History of Central Retinal Vein Occlusion: An Evidence-Based Systematic Review
McIntosh, R. L., Rogers, S. L., Lim, L., Cheung, N., Wang, J. J., Mitchell, P., Kowalski, J. W., Nguyen, H. P., & Wong, T. Y. (2010) · Ophthalmology · doi:10.1016/j.ophtha.2010.01.060 · Cited by 597
Jw, M. (1994) · UCL Discovery (University College London) · Cited by 584
Evaluation of Grid Pattern Photocoagulation for Macular Edema in Central Vein Occlusion
Clarkson, J. G., Chuang, E., Gass, D., Pedroso, M., Cubillas, T., Duria, E. S., Hess, D. J., Rams, I., Ball, M., Gutierrez, A., et al. (1995) · Ophthalmology · doi:10.1016/s0161-6420(95)30849-4 · Cited by 508
Argon Laser Photocoagulation for Macular Edema in Branch Vein Occlusion
Finkelstein, D. (1986) · Ophthalmology · doi:10.1016/s0161-6420(86)33651-0 · Cited by 466
Intravitreal Aflibercept for Macular Edema Following Branch Retinal Vein Occlusion
Campochiaro, P. A., Clark, W. L., Boyer, D. S., Heier, J. S., Brown, D. M., Vitti, R., Kazmi, H., Berliner, A. J., Erickson, K., Chu, K. W., et al. (2015) · Ophthalmology · doi:10.1016/j.ophtha.2014.08.031 · Cited by 385
Research works printed but not linked: 7
- Clark WL, Boyer DS, Heier JS, et al. Intravitreal aflibercept for macular edema following branch retinal vein occlusion 52- week results of the VIBRANT study. Ophthalmology. 2016; 123:330-336.
- Campochiaro PA, Heier JS, Feiner L, et al. Ranibizumab for macular edema following branch retinal vein occlusion: six- month primary end point results of a phase III study. Ophthalmology. 2010;117:1102-1112.e1.
- Minhas G, Anand A. Animal models of retinal ischaemia. In: Agarwal A, ed. Brain Injury -Pathogenesis, Monitoring, Recovery and Management. 1st ed. Rijeka: InTech; 2012: 153.
- Pang I, Clark AF. Animal Models for Retinal Diseases. 1st ed. New York: Humana Press; 2010.
- Iwata T. Animal models for eye diseases. In: Hau J, Schapiro S, eds. Handbook of Laboratory Animal Science. 3rd ed. New York: CRC Press; 2013:195.
- Chan CC. Animal Models of Ophthalmic Diseases. 1st ed. London: Springer International Publishing; 2016.
- Lai CC, Wu WC, Chuang LH, Yeung L, Wei W, Yang KJ. Quantitative grading of preretinal neovascularization in adults rats. Acta Ophthalmol Scand. 2005;83:590-594.
Cited by
VEGFR1 signaling in retinal angiogenesis and microinflammation
Uemura, A., Fruttiger, M., D'Amore, P. A., De Falco, S., Joussen, A. M., Sennlaub, F., Brunck, L. R., Johnson, K. T., Lambrou, G. N., Rittenhouse, K. D., et al. (2021) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2021.100954 · Cited by 354
“In addition, retinal vessel occlusion models have been generated and explored in many different animals, usually with a focus on the vascular and edematous changes and retinal atrophy (Khayat et al., 2017).”
BackgroundJoussen, A. M., Ricci, F., Paris, L. P., Korn, C., Quezada-Ruiz, C., & Zarbin, M. (2021) · Eye · doi:10.1038/s41433-020-01377-x · Cited by 290
“RVO is classified as either central RVO, hemicentral RVO or branch RVO.”
BackgroundInfluentialUpdate on Retinal Vein Occlusion
Romano, F., Lamanna, F., Gabrielle, P., Teo, K. Y. C., Parodi, M. B., Iacono, P., Fraser‐Bell, S., Cornish, E. E., Nassisi, M., Viola, F., et al. (2023) · Asia-Pacific Journal of Ophthalmology · doi:10.1097/apo.0000000000000598 · Cited by 131
Assessment of Inner Blood–Retinal Barrier: Animal Models and Methods
Bora, K., Kushwah, N. S., Maurya, M., Pavlovich, M. C., Wang, Z., & Chen, J. (2023) · Cells · doi:10.3390/cells12202443 · Cited by 71
“…vein occlusion (RVO), characterized by thrombotic obstruction of the retinal veins, results in retinal ischemia and hypoxia, and upregulation of hypoxia-induced growth factors that trigger abnormal neovascularization, vascular leakage, and macular edema leading to impaired vision [10,245,246].”
BackgroundMethodMultimodal Imaging of Microvascular Abnormalities in Retinal Vein Occlusion
Hirano, Y., Suzuki, N., Tomiyasu, T., Kurobe, R., Yasuda, Y., Esaki, Y., Yasukawa, T., Yoshida, M., & Ogura, Y. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10030405 · Cited by 54
“, they differ from older patients with systemic diseases such as diabetes mellitus, hypertension, and hyperlipidemia [98].”
BackgroundEndothelial activation of caspase-9 promotes neurovascular injury in retinal vein occlusion
Avrutsky, M. I., Ortiz, C. K. C., Johnson, K. V., Potenski, A. M., Chen, C. W., Lawson, J. M., White, A. J., Yuen, S. K., Morales, F. N., Canepa, E., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-16902-5 · Cited by 51
Coincident PAMM and AMN and Insights Into a Common Pathophysiology
Iovino, C., Au, A. C., Ramtohul, P., Bacci, T., Albahlal, A. A., Khan, A. M., Al-Abdullah, A. A., Wendel, R., Chhablani, J. K., Sadda, S. R., et al. (2021) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2021.07.004 · Cited by 50
Hirabayashi, K., Tanaka, M., Imai, A., Toriyama, Y., Iesato, Y., Sakurai, T., Kamiyoshi, A., Ichikawa‐Shindo, Y., Kawate, H., Tanaka, M., et al. (2019) · American Journal Of Pathology · doi:10.1016/j.ajpath.2018.10.021 · Cited by 24
“450 fibroblasts, and diathermic cauterization have been proposed.(26) Among them, the photodynamic coagulation method(27) shows early features of the clinical disease, including retinal capillary dropout, hemorrhage, and edema.”
BackgroundMcAllister, I. L., Vijayasekaran, S., Zhang, D., McLenachan, S., Chen, F. K., & Yu, D. (2018) · Experimental Eye Research · doi:10.1016/j.exer.2018.05.025 · Cited by 22
Photodynamic treatment of acute vascular occlusion by using an iron–nitrosyl complex
Choe, J., Kim, S., Kim, J., Baik, M., Lee, J., & Cho, J. (2023) · Chem · doi:10.1016/j.chempr.2023.02.013 · Cited by 17
Excess adiponectin in eyes with progressive ocular vascular diseases
Nishinaka, A., Nakamura, S., Tanaka, M., Masuda, T., Inoue, Y., Yamamoto, T., Imai, T., Hidaka, Y., Shimazawa, M., & Hara, H. (2021) · The FASEB Journal · doi:10.1096/fj.202001740rr · Cited by 17
Gene expression profile analysis of the rabbit retinal vein occlusion model
Neo, T., Gozawa, M., Takamura, Y., Inatani, M., & Oki, M. (2020) · PLoS ONE · doi:10.1371/journal.pone.0236928 · Cited by 15
The Changes in Blood Flow Seen in the Eye after Foot Acupuncture Treatment in Mice
Nishinaka, A., Nitta, K., Seki, T., Hara, H., & Shimazawa, M. (2020) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2020/6405471 · Cited by 14
Avrutsky, M. I., Chen, C. W., Lawson, J. M., Snipas, S. J., Salvesen, G. S., & Troy, C. M. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1209527 · Cited by 13
“The laser-induced murine model of RVO has been used extensively to investigate mechanisms underlying RVO pathology (Khayat et al., 2017).”
MethodBarcode lipids for absolute quantitation of liposomes in ocular tissues
Merivaara, A., Puranen, J., Sadeghi, A., Zashikhina, N., Pirskanen, L., Lajunen, T., Terasaki, T., Auriola, S. O. K., Vellonen, K., & Urtti, A. O. (2024) · Journal of Controlled Release · doi:10.1016/j.jconrel.2024.04.023 · Cited by 9
Ortiz, C. K. C., Neal, A. M., Avrutsky, M. I., Choi, M., Smart, J., Lawson, J. M., & Troy, C. M. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-05387-3 · Cited by 9
“The laser-induced mouse model of RVO [6] is a noninvasive method and one of the best translational avenues to study the role of inflammation [7, 8] and identify signaling pathways involved in RVO pathology [9, 10].”
MethodXu, X.-W., Li, X., Tang, Q., Zhang, Y., Zhang, L., & Zhang, M. (2024) · PLoS ONE · doi:10.1371/journal.pone.0305741 · Cited by 8
Wada, T., Song, Y., Omae, T., Sogawa, K., Yoshioka, T., Nakabayashi, S., Takahashi, K., Tani, T., Ishibazawa, A., Ishiko, S., et al. (2020) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.61.2.34 · Cited by 8
Takahashi, H., Nakagawa, K., Yamada, H., Mori, H., Oba, S., Toyama, K., & Takahashi, K. A. (2021) · Heliyon · doi:10.1016/j.heliyon.2021.e05902 · Cited by 8
Gounari, E., Komnenou, A. T., Kofidou, E., Nanaki, S. G., Bikiaris, D. Ν., Almpanidou, S., Kouzi, K., Karampatakis, V. E., & Koliakos, G. (2022) · Stem Cells International · doi:10.1155/2022/2760147 · Cited by 8
“However, these previously reported animal models have important limitations which despite of the lack of important clinical symptom exhibition and laser-induced in fl ammation in irradiated areas also include immediate spontaneous [36].”
Optimization of the Retinal Vein Occlusion Mouse Model to Limit Variability
Ortiz, C. K. C., Potenski, A. M., Lawson, J. M., Smart, J., & Troy, C. M. (2021) · Journal of Visualized Experiments · doi:10.3791/62980 · Cited by 8
Cehofski, L. J., Kruse, A., Alsing, A. N., Sejergaard, B. F., Nielsen, J. E., Pedersen, S., Muttuvelu, D. V., Kirkeby, S., Honoré, B., & Vorum, H. (2021) · Journal of Ophthalmology · doi:10.1155/2021/6690260 · Cited by 7
“Compression of a retinal vein by an arteriosclerotic artery is not possible to induce in animal models of BRVO [13, 29].”
Implantable anti-angiogenic scaffolds for treatment of neovascular ocular pathologies
Sarkar, B., Siddiqui, Z., Kim, K. K., Nguyen, P. K., Reyes, X., McGill, T. J., & Kumar, V. (2020) · Drug Delivery and Translational Research · doi:10.1007/s13346-020-00753-0 · Cited by 7
“aberrant angiogenesis, retinal edema, inflammation, and vascular leakage) has been observed in the LIPC retinal vein occlusion model [113].”
BackgroundZhao, Y., Ge, Z., Guo, T., Liu, H., Zhou, Y., Chen, J., Xu, H., & Chen, Z. (2025) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.66.5.2 · Cited by 6
“DRIL, a reliable indicator of retinal capillary non-perfusion, 14 and RVO disease progression and visual prognosis, 15–18 was significantly alleviated by SB290157 treat-ment.”
Kim, J. J., Bae, M., Kim, J., Park, W., Jang, J., Won, J. Y., & Cho, D. (2025) · Advanced Composites and Hybrid Materials · doi:10.1007/s42114-025-01455-2 · Cited by 5
“However, species-specific genetic differences, retinal cellular composition variations, ethical concerns, and the high costs associated with animal studies pose significant challenges to their widespread use in preclinical research [15].”
Arteriovenous crossing in retinal vessels of mice, rats, and pigs.
Martin, G., Wefelmeyer, K. L., Bucher, F., Schlunck, G., & Agostini, H. T. (2020) · PubMed Central · Cited by 5
Liu, X., & Fan, F. (2026) · Frontiers in Toxicology · doi:10.3389/ftox.2026.1731947 · Cited by 4
“…such as retinal vein occlusion and macular oedema are also amenable to preclinical modeling, where laser-or occlusion-based paradigms in rodents and larger species reproduce hallmark vascular and edema phenotypes that can be quantified by fundus imaging, and histopathology (Khayat et al., 2017).”
Ischemic retinal vein occlusion: Characterizing the more severe spectrum of retinal vein occlusion.
Călugăru, D. M., & Călugăru, M. (2019) · PubMed · doi:10.1016/j.survophthal.2019.01.006 · Cited by 4
Self-citationA novel model of subretinal edema induced by DL-alpha aminoadipic acid
Xie, Z., Wu, X., Cheng, R., Huang, J., Wang, X., Shi, Q., Xu, B., Paulus, Y. M., Yuan, S., & Liu, Q. (2023) · Experimental Eye Research · doi:10.1016/j.exer.2023.109388 · Cited by 4
Mæng, M. O., Roshanth, N., Kruse, A., Nielsen, J. E., Kjærgaard, B., Honoré, B., Vorum, H., & Cehofski, L. J. (2023) · Medicina · doi:10.3390/medicina59020243 · Cited by 4
“These include shared anatomical similarities with humans, great accessibility for the performance of surgical and diagnostic procedures, and easy availability [27].”
BackgroundMethodInfluentialKhayat, M., Wright, D. M., Yeong, J. L., Xu, D., Donley, C., Lakshmipathy, G. R., Low, M. K., White, N. D., Williams, M. A., & Lois, N. (2019) · Retina · doi:10.1097/iae.0000000000002571 · Cited by 4
Self-citationOccludin acts as a dynein adaptor regulating permeability and collateral angiogenesis
Liu, X., Su, E. J., Dreffs, A. A., Gillies, J. P., Merlino, M. S., Gao, L., Peregoff, J., Lin, C., Ross, M. E., DeSantis, M. E., et al. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2516076122 · Cited by 3
“Previous studies suggested the time frame of 2–4 weeks for retinal collateral vessel growth 32,33 .”
Noma, H., & Mimura, T. (2026) · Antioxidants · doi:10.3390/antiox15030338 · Cited by 3
“These models are well established as experimental platforms for evaluating the contribution of oxidative stress to RVO pathophysiology [54].”
Arroyo, J. G., Seto, B. K., Yamada, K., Zeng, K., Minturn, R. J., & Lemire, C. A. (2021) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-021-05128-w · Cited by 3
RetractedSalkar, A., Palanivel, V., Basavarajappa, D. K., Heng, B., Schulz, A. M., Gupta, V. K., Graham, S. L., Mirzaei, M., & You, Y. (2026) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-25-01905 · Cited by 2
Nakanishi, K., Takamura, Y., Nakano, Y., Inatani, M., & Oki, M. (2025) · Genes to Cells · doi:10.1111/gtc.13196 · Cited by 1
Thrombolytic efficacy and safety of recombinant scu-PA in a rabbit retinal vein occlusion model
Yu, D., Rong, H., Xing, D., Hu, L., Wen, Y., Wang, X., Zhang, W., Fan, H., Zhao, Y., Gong, X., et al. (2025) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2025.177293 · Cited by 1
Retinal optical coherence tomography angiography as a bedside guide for perioperative resuscitation
Patnaik, S. S., Islam, I. S., Rajput, J. S., Albarran, K., Dobariya, A., Dunbar, M. L., Pascual, J. M., & Hoffmann, U. (2026) · Scientific Reports · doi:10.1038/s41598-026-53141-y · Cited by 1
Kokki, E., Karttunen, T., Kettunen, S., Kinnunen, K., Meyer, G. R. Y. D., & Ylä‐Herttuala, S. (2018) · Current Trends in Ophthalmology · doi:10.18314/ctoy.v1i1.1265
Turgut, B. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-15583-3.00002-0
Macular Edema Resistance in Retinal Vein Occlusion and the Protective Role of PAMM Subtypes
Cicinelli, M. V., PEPE, E. M., Tombolini, B., Romanelli, M., Albertini, S., Carlo, M. P. D., Fabbro, S. D., Giuffré, C., Bandello, F. M., & Lattanzio, R. (2025) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2025.09.029 · Cited by 1
Evaluation of a Clover-looped-haptics IOL for Sutured Scleral Fixation in a Porcine Eye Model
Xu, J.-W., Zhu, S., Shi, C., Feng, Y., Zhao, H., Liu, C., Zhang, M., xu, Z. Y., & Xu, W. (2026) · Ophthalmic surgery, lasers & imaging retina · doi:10.3928/23258160-20260122-01
Hu, R., Zeng, C., Cui, H., Li, M., Tang, C., & Li, Q. (2026) · Frontiers in Medicine · doi:10.3389/fmed.2026.1866632
Hu, H. F., Yun, J., Demirkol, A., Cui, X., Liu, S., & Tsang, S. H. (2026) · Disease Models & Mechanisms · doi:10.1242/dmm.052889
Metadata
- Authors
- Khayat, M., Lois, N., Williams, M., & Stitt, A. W.
- Affiliations
- Queen's University Belfast (GB)
- Corresponding author
- Lois, Noemi
- Venue
- Investigative Opthalmology & Visual Science
- Published
- 2017-12-08
- Volume
- 58
- Issue
- 14
- Pages
- 6175
- ISSN
- 0146-0404 (ISSN-L)
- 1552-5783
- OpenAlex
- W2773601578
- Cited by
- 42
- References
- 205
- Citations by year
- 2026: 4 · 2025: 7 · 2024: 3 · 2023: 6 · 2022: 2 · 2021: 9 · 2020: 6 · 2019: 2 · 2018: 3
- FWCI
- 0.55
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Investigative Ophthalmology & Visual Science (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Research Portal (Queen's University Belfast) (submittedVersion, cc-by-nc-nd)
- Funders
- King Abdulaziz University (R8384CEM)
- Topics
- Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Retinal Imaging and Analysis
- Health Sciences › Medicine › Ophthalmology › Retinal and Macular Surgery
- Keywords
- retinal vein occlusion, animal models, branch retinal vein occlusion, central retinal vein occlusion, laser photocoagulation, diathermy, thrombin, PD0325901, retinal hemorrhage, retinal edema, neovascularization, non-human primates, rodents, pigs, rabbits
- MeSH terms
- Animals, Disease Models, Animal, Prognosis, Retinal Vein Occlusion, Visual Acuity
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.